The present study is to investigate the phytochemical content, cytotoxicity and antiviral activity of the crude and fractions from Marrubium vulgare.
INTRODUCTION
Acute and recurrent herpes simplex virus type 1 (HSV-1) infections remain an important problem due to the emergence of acyclovir (ACV) resistant virus that makes the search for novel antiviral substances imperative. Potential anti-herpes activity of bioactive compounds from numerous plant species have been investigated (Allahverdiyev et al., 2004; Verma et al., 2008) . HSV-1 is a DNA virus that causes a variety of diseases in humans. In some instances, HSV-1 is a major threat to immunecompromised patients (Serkedjieva et al., 1999; Chuanasa et al., 2008) . The present study thus sought to screen a medicinal plant, Marrubium vulgare for the safety and potential in anti-virus therapy. M. vulgare grows in the wild and commonly known as "Horehound" belongs to the Lamiaceae family (Masoodi et al., 2008) . It has been used in folk medicine and reported to possess a wide range of biological activities and pharmacological properties. This plant has been previously reported to have antihypertensive activity (El-Baradai et al., 2004) , exhibiting vasorelaxant (El-Baradai et al., 2003a; 2003b ), anti-diabetic (Elberry et al., 2011 Boudjelal et al., 2012) , anti-oxidant (Kadri et al., 2011) , anti-inflammatory, analgesic, anti-bacterial (Masoodi et al., 2008; Kanyonga et al., 2011) and antioedematogenic (Stulzer et al., 2006) activities. However, bibliographic searches reveal that there is a dearth of information on its antiviral activity against HSV-1. In this study, various fractions of the M. vulgare were determined for their phytochemical constituents. The cytotoxicity and antiviral activity against HSV-1 evaluated for the crude and fractions to determine the potential as antiviral agents. The viral attachment and virus yield assays carried out for the hexane fraction to determine the preliminary mode of action.
MATERIALS AND METHODS

Plant extraction
The powder of the whole plant (including root, stem, leaves, flowers and seeds) of M. vulgare was purchased from Alibaba Company (Hong Kong, China). The crude extract was prepared following the method of Masoodi et *Corresponding author al. (2008) with minor modification. The powder of the whole plant (50 g) was filled in the thimble of Soxhlet apparatus and extracted with methanol for up to 9 h. Thereafter, it was filtered and the filtrate was centrifuged at 4000 rpm for 15 min. The supernatant was collected and the solvent was concentrated and dried by rotary evaporator and kept at 4 °C until used.
Plant fractions were prepared following the method of Ilango et al. (2009) and Ramkumar et al. (2007) with slight modifications. Dried powder (200 g) was dispensed in the thimble of a Soxhlet apparatus and extracted with distilled water and methanol (1:2) for up to 15 h. The methanol from the resulting extract was removed by rotary evaporation and the liquid part successively partitioned (3×50 mL) with hexane, chloroform, ethyl acetate and nbutanol yielding four fractions. These fractions were filtered and concentrated under reduced pressure. Subsequently, the obtained aqueous fraction was lyophilized.
Phytochemical analysis
Phytochemical analysis of the crude extract and four fractions was established according to standard procedures used to test for the presence of alkaloids, carbohydrates, saponins, tannins, flavones glycones, steroids, terpenes and anthraquinone as described by Kasolo et al. (2010) and Edeoga et al. (2005) .
Cells and virus
Vero cell lines from the stock collection of the Virology Laboratory, School of Biosciences and Biotechnology were grown in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 5% fetal bovine serum, penicillin/streptomycin (100 U/L) and non-essential amino acids. Cell culture was maintained at 37 °C under a humidified 5% CO2 atmosphere. A clinical isolate of HSV-1 was propagated in Vero cells and incubated at 37 °C until the cytopathic effect develops. The titer of virus was estimated and stored at -80 °C until used.
Cytotoxicity assay
Evaluation on the crude and fraction cytotoxicity towards Vero cells was performed using MTT [3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyl tetrazolium bromide] assay. Vero cells (2×10 5 cells/mL) were prepared in 96 well tissue culture plates, after a 24 h period of incubation at 37 °C under a humidified 5% CO2 atmosphere. The medium was removed from the wells, and 100 µL of dilutions of the crude extract and fractions (70 µg/mL to 600 µg/mL concentration prepared in cell culture medium) were added to each well. Control cells were added with only 100 µL of the medium. The plates were incubated for 3 days under the same conditions mentioned above. Subsequently, the medium was removed and the cells washed by phosphate buffer saline (PBS) followed by the addition of 100 µL of DMEM and 10 µL of MTT to each well. The plates were then incubated for 3 h. The MTT solution was then removed and 130 µL of dimethyl sulfoxide (DMSO) was added to each well to dissolve the formazan crystals, followed by gentle shaking for 15 min. Absorbance was determined spectrophotometrically on a multi-well plate reader at 540 nm. The CC50 was defined as the cytotoxic concentration of each extract that reduced the absorbance of treated cells to 50% when compared with that of the control cells (Akanitapichat et al., 2005; Capua et al., 2010) . CC50 values were calculated using regression analysis.
Antiviral activity
Vero cell line (2×10 5 cells/ mL) was prepared in 24 wells (500 µL in each well). When the cells is 80-90% confluent, the medium was removed from the wells. HSV-1 at 50 pfu and DMEM were added subsequently to the cells and incubated for 1 h. The medium was removed and different concentrations of crude extract and fractions (concentration is less than the CC50 values) were added to the methyl cellulose (MC) which was applied to the cells. This was then incubated for two days. After the plaques appeared, the plates were stained with crystal violet and shaken for about 30 min, followed by gentle washing. The plates were left to dry and the number of plaques was counted using an inverted microscope. The IC50 was defined as the concentration of the extracts that inhibit 50% of the plaques in virus infected cells compared to control (Yew et al., 2002) . The mean number of plaques was used to calculate the percentage of plaques inhibited. A curve relating percent plaque inhibition against extract concentrations was used to calculate the inhibitory concentration that elucidated a 50% reduction of cell viability (IC50). The experiments were performed in triplicates with the mean values represent three experiments
Attachment assay
This assay was carried out by mixing virus and the hexane fraction with different concentrations and incubated at room temperature one minute. Vero cell monolayer was grown in 12 well culture plate and then pre-chilled at 4 °C for 1 h. The medium was aspirated and the cell monolayer was infected with 100 a plaque-forming unit (PFU)/well of HSV-1 in the absence or presence of different concentrations of hexane fraction, then incubated at 4 °C for another 3 h. The medium was aspirated to remove virus inoculum and cell monolayer was washed with PBS and overlaid with medium containing 1% methylcellulose. The cell monolayer was incubated for a further 48 h before it was fixed and stained. The 
Virus yield reduction assay
Monolayers of Vero cells grown in 12 well plates were infected with 100 pfu/well of HSV-1 for 2 h at 37 °C in 5% CO2. The inoculum was removed and hexane fraction at concentrations 20-100 μg/mL in DMEM with 5% FBS was added. At 30 h after viral infection, the infected cells were lysed by freezing and thawing three times. The supernatant was obtained by centrifugation at 3000 rpm for 10 min at 4 °C. A serial dilution of each supernatant was prepared in DMEM and the surviving virus titer was determined by the plaque assay (Saddi et al., .2007 )
RESULTS AND DISCUSSIONS
Phytochemical content
The presence of active compounds from different fractions of M. vulgare is shown Abadi et al. (2013) and Verma et al. (2012) reported that M. vulgar essential oils contains major components including tetramethyl heptadecan-4-olid, germacrene d-4-ol, α-pinéne, phytol, dehydro-sabina ketone, piperitone, δ-cadinene, 1-octen-3-ol and benzaldehyde. Terpene compounds isolated from the oils includes linalool, 1-8-cineole, thymol, marrubiin (Zawislak, 2012) . In this study, the methanol crude extract of M. vulgare showed the highest level of inhibitory effect on HSV-1 followed by the hexane fraction. Phytochemical analysis showed that the crude and the hexane fraction contain compounds of terpenes and anthraquanins. According to Astani et al. (2011) , sesquiterpenes were able to suppress viral infection by 40-98% and directly inactivate herpes virus by interfering with virion envelope structures or mask viral structures that are necessary for adsorption or entry into host cells. Soares et al. (2012) also identified the meroditerpenoid atomaric acid from the Stypopodium zonale extracts as anti-HSV-1. According to Aref et al. (2011) triterpenes showed activity against HSV-1 and their mode of action was found at all stages of multiplication. Sydiskis et al. (1991) demonstrated that the anthraquinones acted directly on the envelope of HSV-1, resulting in the prevention of virus adsorption and subsequent replication. Table 2 shows the CC50 values of the crude extract and the fractions towards Vero with the value of more than 20 µg/mL indicating that the samples were non cytotoxic (Moo-Puc et al., 2009; Chandrashekar et al., 2011) . Thus, the antiviral activity is now worth to be demonstrated for the potential as antiviral agents.
Antiviral activity
Hexane fraction displayed antiviral activity compared to other fractions as 80% of inhibition was achieved at 100 µg/mL and an associated IC50 value of 50 µg/mL (Table  2) . Both crude extract and chloroform fraction indicated a reduction in the number of plaques by 72% and 55% at 150 µg/mL and IC50 values respectively being 90 µg/mL and 140 µg/mL. On the other hand, no activity was detected in the ethyl acetate or n-butanol fractions. The selective index (SI) was determined to associate the cytotoxicity and the antiviral potential of the tested crude and fractions as shown in Table 2 . In this study, only the crude extract, hexane fraction and chloroform fraction displayed safe antiviral activity. The effective concentrations of crude, hexane, chloroform fractions were 150 µg/mL, 100 µg/mL and 150 µg/mL respectively. We isolated the pure compound and tested for antiviral activity (data not shown). However, when compared with the methanolic crude of the whole plant, chloroform and hexane fractions in the cytotoxicity assay, it was found to be less active in antiviral activity with the selective indices was less than 2 (1.7). Thus in this study, we continue to evaluate the fraction with selective index more than 2 and higher (Aschenbrenner and Venable, 2009 ). In this study, the selective index or SI of crude, hexane and chloroform fractions were more than 1 thus can be accepted and at least not dangerous. For use as topical agents, drugs should not have SI less than 1. Most drugs have a selective index of 2 or higher. Drugs with SI of 5 or 10 are safer drugs (Aschenbrenner and Venable 2009; Omonike et al., 2013) .
The hexane fraction was effective when it was added in parallel with the virus to cells. This observation suggests that the hexane fraction might disrupt the early steps of cyclic replication, including obstruction of viral attachment. HSV-1 attachment was inhibited by hexane fraction in a dose-dependent manner at 100 µg/ mL, 90 µg/mL and 80 µg/mL with the percentage of inhibition was 44%, 33% and 18% respectively.
The complete HSV-1 replication cycle takes approximately 18 to 20 h (Bacon et al., 1996) but in this study the replication cycle takes place in 30 h. Figure 2 shows the virus yields of HSV-1 in Vero cells as control or treated with varying concentrations of hexane fraction. Hexane fraction reduced the virus yields in a dose dependent manner. The highest concentration of 100 μg/mL reduced the yields to less than 1 x 10 2 pfu/mL. A 90 μg/mL, the fraction reduced the virus yields to 2.4×10 2 pfu/mL and at 80 µg/mL the virus yield was reduced to the half amount estimated in control cells. Antiviral activities of some Lamiaceae species have been reported in previous studies. The extract of Thymus vulgaris has been reported to show high level of antiviral activity against HSV-1 and HSV-2 (Behravan et al., 2011) . Several compounds such as carvacrol, thymol, anthraquinones, especially the polyphenolics, polysulphonates and monoterpenes derived from Lamiaceae have been shown to possess antimicrobial or antiviral activity. Most extracts exhibit their effects on viral particles prior to attachment to host cell or post-infection of the cell. Flavonoids exhibit antiviral effects via inhibiting the RNA synthesis of viruses and polyphenols act principally by binding to the protein coat, thus preventing absorption of the virus (Esimone et al., 2007; Behravan et al., 2011) . In the study conducted by Amoros et al. (1987) , saponin isolated from the Anagallis arvensis plant was reported to inhibit adhesion and penetration of HSV-1 to Vero cell. In another study, conducted by AndrighettiFrohner et al. (2005) Hsiang and Ho (2008) investigated the action of emodin on HSV-1, the result indicated that the emodin possesses antiviral activities via the inhibition both UL12 and CK2 and disruption of the phospholipid bilayer of the envelope. A study carried out by Zandi et al. (2007) revealed that hot glycerine Aloe vera extract which contains anthraquanins could be a good choice for preventing of virus adsorption, attachment or entry to the host cell. Cohen et al. (1996) reported that the most active anthraquinone was 5,7-dichloroemodin against HSV-1 compared to (2, (6) (7) (8) 13) anthraquinones. Further confirmation on the active compounds available in M. vulgare however, needs to be done in the future.
In summary, our findings suggest that M. vulgare contains antiviral active compounds especially in the crude extract and hexane fraction. This set the stage for future studies on the plant for the development of topical agents against HSV-1. In doing so, the mechanism of action of the active compound from this plant is worthy to be determined. Furthermore, the compound which is responsible to work singly or synergistically in their contribution to disintegrate the envelope of the virus must be determined.
